Migraine prophylaxis with drugs influencing the renin-angiotensin system

European Journal of Neurology

Volumn 14, Issue 7, 2007, Pages 713-714

  Stovner, L J ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; PLACEBO;

BLOOD BRAIN BARRIER; CLINICAL TRIAL; COUGHING; DRUG EFFICACY; DRUG INDUSTRY; DRUG TOLERABILITY; EDITORIAL; HEADACHE; HUMAN; MEDICAL RESEARCH; MIGRAINE; PRIORITY JOURNAL; PROPHYLAXIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UNSPECIFIED SIDE EFFECT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; CLINICAL TRIALS; HUMANS; LISINOPRIL; MIGRAINE DISORDERS; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES;

EID: 34347336576     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01760.x     Document Type: Editorial

References (11)

1. Andlin-Sobocki P, Jönsson B, Wittchen H-U, Olesen J. Cost of disorders of the brain in Europe. European Journal of Neurology 2005 12 (Suppl. 1 1 27.
2. Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R. Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study. European Journal of Epidemiology 2005 20 : 1007 1014.
3. Sicuteri F. Enkephalinase inhibition relieves pain syndromes of central dysnociception (migraine and related headache). Cephalalgia 1981 1 : 229 232.
4. Bender WI. ACE inhibitors for prophylaxis of migraine headaches. Headache 1995 35 : 470 471.
5. Etminan M, Levine MA, Tomlinson G, Rochon PA. Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis. American Journal of Medicine 2002 112 : 642 646.
6. Onder G, Pahor M, Gambassi G et al. Association between ACE inhibitors use and headache caused by nitrates among hypertensive patients: results from the Italian group of pharmacoepidemiology in the elderly (GIFA). Cephalalgia 2003 23 : 901 906.
7. Rahimtoola H, Buurma H, Tijssen CC, Leufkens HG, Egberts AC. Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibition therapy - a pilot study. Pharmacoepidemiology and Drug Safety 2004 13 : 41 47.
8. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 2001 322 : 19 22.
9. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 2003 289 : 65 69.
10. Tronvik E, Stovner LJ, Schrader H, Bovim G. Involvement of the renin-angiotensin system in migraine. Journal of Hypertension Supplement 2006 24 : S139 S143.
11. Schuh-Hofer S, Flach U, Meisel A, Israel H, Reuter U, Arnold G. Efficacy of lisinopril in migraine prophylaxis-an open label study. European Journal of Neurology 2007 14 : 701 703.